ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Corindus Vascular Robotics Inc

Corindus Vascular Robotics Inc (CVRS)

4.27
0.00
(0.00%)
Closed 30 January 8:00AM
4.27
0.00
( 0.00% )
Pre Market: 11:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.27
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
4.27
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CVRS Latest News

Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers

At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the...

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference

Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment Corindus Vascular Robotics, Inc...

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology Corindus Vascular Robotics, Inc. (“Corindus” or the...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc. PR Newswire NEW YORK, Aug. 8, 2019 NEW YORK, Aug. 8, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Corindus Reports Second Quarter 2019 Results

Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of...

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

-- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion -- Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of...

Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, and David...

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release second quarter 2019 financial and business results...

Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities

One of the nation’s largest hospital networks adopts vascular robotic technology in multiple hospital locations to treat patients in need of cardiovascular care Corindus Vascular Robotics, Inc...

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CVRS - Frequently Asked Questions (FAQ)

What is the current Corindus Vascular Robotics share price?
The current share price of Corindus Vascular Robotics is US$ 4.27
What is the 1 year trading range for Corindus Vascular Robotics share price?
Corindus Vascular Robotics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JOBGEE Group Inc
US$ 0.2798
(16.83%)
1
MXCMexco Energy Corp
US$ 12.98
(12.31%)
5
SQYYieldMax SQ Option Income Strategy ETF
US$ 20.08
(11.74%)
164
YCBDcbdMD Inc
US$ 0.60
(9.09%)
43.94k
GNSGenius Group Limited
US$ 0.54
(9.05%)
5.93k
AWXAvalon Holdngs Corp
US$ 2.90
(-19.22%)
300
INLXIntellinetics Inc
US$ 11.20
(-17.46%)
10
SVTServotronics Inc
US$ 9.01
(-15.00%)
122
SGNSigning Day Sports Inc
US$ 3.74
(-13.82%)
72.84k
CIXCompX International Inc
US$ 22.11
(-13.60%)
5
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.36
(-6.16%)
1.09M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26.675
(3.87%)
705.39k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 9.90
(3.13%)
361.08k
ETHU2x Ether ETF
US$ 6.79
(5.19%)
323.16k
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 20.895
(-4.06%)
298.65k

Discussion

View Full Feed
Flexplate Flexplate 8 minutes ago
Gitreal, enough on your P. Geo claims. Yes, in Canada for a mining company to be listed on a Canadian exchange, a NI 43-101 report must be filed and signed off by a P. Geo.... that is not a requirement for the U.S. stock exchange. The U.S. stock exchange uses the S-K 1300 report which, does not requ
NBRI
capgain capgain 9 minutes ago
:) They didn't know what to do!
LVerstee LVerstee 11 minutes ago
(6) 30th = planned staff meeting in India

Venue? Must be very crowded. Folks, we're talking about crowds like you've never seen before. Huge, absolutely huge. Can you believe it? People are saying they've never witnessed anything like it. Believe me, nobody's ever seen crowds like thi
ITUP
capgain capgain 13 minutes ago
LOL
capgain capgain 15 minutes ago
(It sickens me that the Federal government employs two million people -- with retirement funds and benefits not available in the private sector.)

Amazing isn't it?

Go, Trump!
TrendTrade2016 TrendTrade2016 21 minutes ago
PINK WEEKLY CHART SAYS NO GO...I GRABBED .135C VM OFF THAT DUMP
PYNKF
weedtrader420 weedtrader420 21 minutes ago
✊😎☝️ 🌎🚀 I think by the end of February 🦾XRP should be up around $10 🍰
XRPUSD
ducci1 ducci1 22 minutes ago
Gold --/GC---New Hi 2813 !! --Gurus Targeting 3250 !
SPY
Krombacher Krombacher 24 minutes ago
The U.S. Securities and Exchange Commission (SEC) has implemented a new rule, commonly referred to as the "13f-2" rule, which mandates that institutional investment managers disclose significant short positions. Specifically, managers are required to report gross short positions of $10 million or mo
ERHE
ducci1 ducci1 26 minutes ago
Charts: ES Support 6087---SPX Support 5975--5980------Resistance 6099-----ES & SPX Ridin Da 5 min Red Lines !!
SPY
carvajal carvajal 27 minutes ago


You’ve published these links a gazillion times, yet you’
HMBL
SkeBallLarry SkeBallLarry 27 minutes ago
*LIVE*~ Kash Patel Testifies at Senate Confirmation Hearing for FBI Director – 1/30/25

President Trump‘s nominee for FBI director, Kash Patel, will testify at a Senate confirmation hearing
on Thursday, January 30, 2025, at 9:30 am EST. Join RSBN LIVE at 8:30 am.
SkeBallLarry SkeBallLarry 28 minutes ago
*LIVE*~ Kash Patel Testifies at Senate Confirmation Hearing for FBI Director – 1/30/25

President Trump‘s nominee for FBI director, Kash Patel, will testify at a Senate confirmation hearing
on Thursday, January 30, 2025, at 9:30 am EST. Join RSBN LIVE at 8:30 am.
SkeBallLarry SkeBallLarry 30 minutes ago
*LIVE*~ Kash Patel Testifies at Senate Confirmation Hearing for FBI Director – 1/30/25

President Trump‘s nominee for FBI director, Kash Patel, will testify at a Senate confirmation hearing
on Thursday, January 30, 2025, at 9:30 am EST. Join RSBN LIVE at 8:30 am.
nowwhat2 nowwhat2 30 minutes ago
Never went with VM (glad I never did - Even tho it's nice what they are doing)
Went with these guys instead.......fwiw
https://biotuesdays.com/2025/01/24/social-capitals-chamath-palihapitiya-calls-out-perimeters-ai-driven-cancer-margin-visualization-technology-on-x-show/

PYNKF
SkeBallLarry SkeBallLarry 30 minutes ago
*LIVE*~ Kash Patel Testifies at Senate Confirmation Hearing for FBI Director – 1/30/25

President Trump‘s nominee for FBI director, Kash Patel, will testify at a Senate confirmation hearing
on Thursday, January 30, 2025, at 9:30 am EST. Join RSBN LIVE at 8:30 am.
SkeBallLarry SkeBallLarry 31 minutes ago
" Soo sad " .. !! . G'Morning, Red " .. !
ducci1 ducci1 32 minutes ago
Pivot Calcs: SPX Pivot--6038----R1--6064----R2--6088----S1--6014----S2--5988-----ES Pivot--6081----R1--6121----R2--6144----S1--6058--S2--6018 ---Crazy Day---!!LOL!!
SPY
Bizreader Bizreader 32 minutes ago
This is all about control of the ... everything or anything that assures them greater profits regardless of any other values! And this has not been news for many of us for a long time! I'm glad to see that maybe the facts are making themselves quite apparent so at least we know what work there is to
COOP
236T568 236T568 41 minutes ago
Spending freeze mess shows Trump’s pick isn’t right for OMB

The nominee’s combative disdain for Congress’s power of the purse makes him unqualified.

https://wapo.st/3EgB2t6
Orange Cassidy Orange Cassidy 43 minutes ago
And you have the nerve to call the bashers "retards" You live in a state the size of most countries yet know what exactly is going on in that exact spot! "knowing what you own" is part of the pumpers mantra!
. I live in California so I know a lot of what they have already posted is honest and
NBRI
jxyzobrien jxyzobrien 44 minutes ago
there is hope
ron desantis is fighting extreme attempts by florida legislature to pass extreme deportation measures
I am amazed.
Trump had an approval rating 34 when he left office. One of the lowest ever. Americans have very poor memories but those memories can be restored
vuletini vuletini 44 minutes ago
now what...
XRPUSD